CRISPR/Cas9 technology generated a phenylalanine to cysteine substitution at amino acid 802 (F802C). This corresponds to the human F814C mutation identified in familial episodic pain. (J:268091)
查看原文 参与反馈
CRISPR/Cas9 technology generated a phenylalanine to cysteine substitution at amino acid 802 (F802C). This corresponds to the human F814C mutation identified in familial episodic pain. (J:268091)